Ignite Creation Date:
2025-12-25 @ 12:36 AM
Ignite Modification Date:
2025-12-25 @ 10:44 PM
Study NCT ID:
NCT01023867
Status:
COMPLETED
Last Update Posted:
2016-01-06
First Post:
2009-11-30
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Clinical Trial of Donepezil Between the Patients With Alzheimer's Disease and Mixed Dementia
Sponsor:
Samsung Medical Center
Organization:
Study Overview
Official Title:
Comparative Assessment of Clinical Efficacy of Donepezil Between the Patients With Alzheimer's Disease and Mixed Dementia
Status:
COMPLETED
Status Verified Date:
2016-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To compare the clinical efficacy of donepezil between patients with Alzheimer's disease and Mixed Dementia.
Detailed Description:
The purposes of this study are:
1. to compare the clinical efficacy of donepezil between patients with Alzheimer's disease and Mixed Dementia
2. to help to clinicians in choosing the best treatment for patients with mixed dementia
1. to compare the clinical efficacy of donepezil between patients with Alzheimer's disease and Mixed Dementia
2. to help to clinicians in choosing the best treatment for patients with mixed dementia
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: